Maria Serova Selected Research

Maria Serova Research Topics

Disease

20	Neoplasms (Cancer) 06/2016 - 11/2003
4	Colonic Neoplasms (Colon Cancer) 05/2010 - 04/2006
3	Breast Neoplasms (Breast Cancer) 04/2006 - 11/2003
2	Renal Cell Carcinoma (Grawitz Tumor) 06/2016 - 05/2013
2	Hepatocellular Carcinoma (Hepatoma) 08/2015 - 05/2013
2	Neoplasm Metastasis (Metastasis) 03/2014 - 12/2013
2	Squamous Cell Carcinoma of Head and Neck 12/2013 - 07/2008
1	Atrial Fibrillation 01/2020
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2012
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2012
1	Primitive Neuroectodermal Tumors (PNET) 09/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2011
1	Necrosis 05/2010
1	Head and Neck Neoplasms (Head and Neck Cancer) 07/2008
1	Ovarian Neoplasms (Ovarian Cancer) 04/2006

Drug/Important Bio-Agent (IBA)

4	Everolimus FDA Link 06/2016 - 08/2010
3	Sunitinib (Sutent)FDA Link 06/2016 - 09/2012
3	Sorafenib (BAY 43-9006)FDA Link 06/2016 - 05/2013
3	Antineoplastic Agents (Antineoplastics)IBA 09/2014 - 04/2008
3	Galectin 1 (LGALS1)IBA 09/2014 - 06/2012
3	MTOR InhibitorsIBA 05/2013 - 06/2011
3	TOR Serine-Threonine KinasesIBA 09/2012 - 08/2010
3	Protein Kinase CIBA 05/2010 - 04/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2015 - 05/2010
2	compound 0118IBA 09/2014 - 06/2012
2	temsirolimus FDA Link 05/2013 - 08/2010
2	Sirolimus (Rapamycin)FDA Link 05/2013 - 07/2008
2	Phosphotransferases (Kinase)IBA 05/2013 - 07/2008
2	Messenger RNA (mRNA)IBA 03/2013 - 05/2010
2	VimentinIBA 12/2012 - 05/2010
2	Angiogenesis InhibitorsIBA 09/2012 - 06/2012
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2012 - 09/2005
2	Cisplatin (Platino)FDA LinkGeneric 09/2011 - 04/2006
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2011 - 04/2006
2	Paclitaxel (Taxol)FDA LinkGeneric 09/2011 - 07/2008
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2011 - 04/2008
2	3-ingenyl angelateIBA 05/2009 - 04/2008
2	AmphiregulinIBA 09/2005 - 11/2003
1	Clostridium perfringens epsilon-toxinIBA 01/2020
1	Axitinib (AG 013736)IBA 06/2016
1	LY-2157299IBA 08/2015
1	Adenosine Triphosphate (ATP)IBA 08/2015
1	saccharide-binding proteinsIBA 09/2014
1	Biomarkers (Surrogate Marker)IBA 12/2013
1	ChemokinesIBA 12/2013
1	elisidepsinIBA 03/2013
1	Proteins (Proteins, Gene)FDA Link 03/2013
1	LigandsIBA 12/2012
1	Chemokine ReceptorsIBA 12/2012
1	calix(4)areneIBA 06/2012
1	PlatinumIBA 09/2011
1	cis-diammine(pyridine)chloroplatinum(II)IBA 09/2011
1	Gemcitabine FDA Link 09/2011
1	Fluorouracil (Carac)FDA LinkGeneric 09/2011
1	Cyclin D1IBA 06/2011
1	Protein Kinases (Protein Kinase)IBA 05/2010
1	Cadherins (E-Cadherin)IBA 05/2010
1	enzastaurinIBA 05/2010
1	Protein Kinase C betaIBA 05/2010
1	StaurosporineIBA 05/2009
1	Carboplatin (JM8)FDA LinkGeneric 07/2008
1	Cytotoxins (Cytolysins)IBA 04/2008
1	Protein Isoforms (Isoforms)IBA 04/2008
1	Mitogen-Activated Protein KinasesIBA 04/2008
1	ingenolIBA 04/2008
1	lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA 08/2006
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2006
1	IsoenzymesIBA 08/2006
1	irofulvenIBA 04/2006
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 09/2005
1	Complementary DNA (cDNA)IBA 09/2005
1	Antisense RNA (Anti-Sense RNA)IBA 09/2005
1	Matrix Metalloproteinases (MMPs)IBA 11/2003
1	Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA 11/2003
1	Epidermal Growth Factor (EGF)IBA 11/2003

Therapy/Procedure

7	Therapeutics 06/2016 - 08/2006